Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLIF.L Regulatory News (GLIF)

  • There is currently no data for GLIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CLO test results

16 Sep 2009 07:30

RNS Number : 1252Z
T2 Income Fund Limited
16 September 2009
 

T2 Income Fund Limited ("T2" or the "Company")

Monthly CLO Test Results

The Company announces the test results as of 2 September 2009 pursuant to the indenture of the Company's subsidiary, T2 Income Fund CLO I Ltd (the "CLO"). The report summarising the results of those tests can be found at the link below:

http://www.rns-pdf.londonstockexchange.com/rns/1252Z_-2009-9-15.pdf

With respect to the various tests required under the CLO indenture, on 14 September 2009, the CLO passed all collateral coverage tests and all of the loans held within the CLO continue to pay the interest due. 

It should be noted that the implications of failing the collateral coverage tests are very complicated, and the consequences could include interest diversion, principal repayment, or limitations on reinvestment of available cash balances. 

Distinct from the collateral coverage tests are the percentage limitation tests. The consequence of failing these percentage limitation tests is simply that each new investment made by the CLO must "maintain or improve" the test result.

The CLO failed four portfolio percentage limitation tests, two of which relate to limitations on loans rated CCC+/Caa1 and lower by S&P and Moody's, respectively, one related to the highest single obligor for non-senior secured loans and one related to the minimum percentage of senior secured loans required to be outstanding.

The failure of the senior secured loan minimum percentage was due to the amount of cash held within the CLO ($32.1 million); cash is excluded when calculating the percentage of senior secured loans. The Company believes that the substantial cash balance provides an opportunity to acquire better-rated securities at discounts to their par value, which should help to improve the quality of the portfolio as well as improve the CLO's collateral test coverage ratios under a variety of scenarios. As cash is invested in new senior secured loans, this failure should be cured automatically. Although no new investments rated CCC+/Caa1 or lower have been made by the manager for some time, the failure of CCC+/Caa1 percentage limitations tests occurred due to historic and ongoing downgrades of companies by S&P and Moody's. The manager continues to evaluate opportunities to reduce the amount of these loans in situations where a sale could be achieved without incurring substantial principal losses.

The failure of the highest single obligor for non-senior secured ("second lien") loans percentage was due to the sale of certain loans at the CLO's option in August , due to credit concerns, at a realized loss, which reduced the aggregate collateral balance from approximately $303 million in July 2009 to $297 million in August 2009. Since there is a single non-senior secured loan of $9.0 million currently outstanding, the 3.0% maximum limit percentage was violated. However, this specific test is a "maintain and improve" covenant and thus does result in interest diversion or principal paydown.

These covenant violations described above do not have a material impact on the CLO's ability to invest in new loans, and all of the loans held within the CLO continue to pay the interest due.

The next payment test date is 2 October 2009. While we continue to monitor the situation closely, we currently have only limited visibility with respect to which of the CLO tests may or may not be met on that date or other future dates, and whether any further principal paydowns or interest diversions may occur and, if so, the magnitude of those paydowns or diversions.  

While the current month's test results are not controlling as to the 2 October 2009 payment test, it may be worth noting that, had this been a payment test, there would not have been an interest diversion.

As described in previous press releases, the CLO indenture contains a variety of covenants, compliance with which could be made more difficult or impossible should credit markets deteriorate or the loans held by the CLO fail to make expected payments or otherwise not perform.

Contacts:

Geoffrey MillerT2 Income Fund Limited+353 1 4433 466

Patrick ConroyT2 Income Fund Limited+1 203 983 5282

Philip SecrettNominated AdviserGrant Thornton UK LLP+44 (0) 20 7383 5100

Jos TrustedSinger Capital Markets Limited +44 (0) 20 3205 7622

Ed Gascoigne PeesFinancial Dynamics+44 (0) 20 7269 7132

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIFFFLASIELIA
Date   Source Headline
19th Dec 201612:04 pmRNSDirector/PDMR Shareholding
14th Dec 20166:19 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
14th Dec 20167:00 amRNSSCRIP DIVIDEND SHARES - ADDITIONAL LISTING
2nd Dec 20167:00 amRNSIssue of Ordinary Shares
17th Nov 20167:00 amRNSPublication of Net Asset Value
8th Nov 20167:00 amRNSIssue of new securitised loan note
2nd Nov 20167:00 amRNSListing of Corporate Bonds
20th Oct 20165:06 pmRNSIssue of Ordinary Shares
19th Oct 20167:00 amRNS2016 Third Interim Dividend
3rd Oct 20168:27 amRNSCompletion of asset disposals
26th Sep 20167:02 amRNSDirectorate Change
26th Sep 20167:01 amRNSChange of Adviser
26th Sep 20167:00 amRNSHalf-year Report
20th Sep 20165:25 pmRNSDirector/PDMR Shareholding
16th Sep 20161:21 pmRNSResult of Extraordinary General Meeting
15th Sep 20167:00 amRNSSCRIP DIVIDEND SHARES - ADDITIONAL LISTING
13th Sep 20163:00 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES)
13th Sep 20162:51 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
13th Sep 20162:50 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1st Sep 20164:30 pmRNSTotal Voting Rights
18th Aug 20163:05 pmRNSDirector/PDMR Shareholding
18th Aug 20167:00 amRNSPublication of Circular & Notice of EGM
17th Aug 20164:40 pmRNSDirector/PDMR Shareholding
16th Aug 20162:05 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16th Aug 20161:12 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
16th Aug 20161:09 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
11th Aug 20166:03 pmRNSCompletion of Placing
9th Aug 20167:00 amRNSUnderwritten placing and strategic update
2nd Aug 20168:47 amRNSSenior Management Team Appointments
29th Jul 20169:32 amRNSHolding(s) in Company - Platform Black
29th Jul 20167:00 amRNSHolding(s) in Company - Platform Black
25th Jul 20165:07 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
22nd Jul 20167:00 amRNSPublication of Net Asset Value
21st Jul 20164:45 pmRNS2016 Second Interim Dividend.
8th Jul 201611:15 amRNSChange of External Auditor and Registrar
6th Jul 201612:53 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1st Jul 20169:07 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
30th Jun 20164:17 pmRNSCompletion of Acquisitions,Issue of Equity & Bonds
28th Jun 201612:43 pmRNSAcquisition of FundingKnight
20th Jun 20167:00 amRNSDirector/PDMR Shareholding
17th Jun 20161:10 pmRNSPublication of Bond Circular
16th Jun 20167:00 amRNSSCRIP DIVIDEND SHARES - ADDITIONAL LISTING
6th Jun 20161:05 pmRNSResult of Extraordinary General Meeting
3rd Jun 20162:20 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
24th May 20167:00 amRNSCompletion of Share Sale
19th May 20165:12 pmRNSResult of Annual General Meeting
17th May 20167:00 amRNSShares into Treasury
16th May 20167:00 amRNSProposed acquisition of interests & notice of EGM
9th May 20167:00 amRNSPublication of Net Asset Value
27th Apr 201610:03 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.